[Synthesis of derivatives of perhydroazepine, perhydro-1,5-oxazocine, morpholine and piperazine containing 3-(isopropylamino)-propan-2-ol group--compounds with potential effect on the circulatory system and central nervous system].
D001381:Azepines / Q000138:chemical synthesis / Q000494:pharmacology*; D001775:Blood Circulation / Q000187:drug effects*; D002490:Central Nervous System / Q000187:drug effects*; D006801:Humans; D009025:Morpholines / Q000138:chemical synthesis / Q000494:pharmacology*; D010079:Oxazocines / Q000138:chemical synthesis / Q000494:pharmacology*; D000077489:Piperazine; D010879:Piperazines / Q000138:chemical synthesis / Q000494:pharmacology*
D001381:Azepines; D009025:Morpholines; D010079:Oxazocines; D010879:Piperazines; D000077489:Piperazine; C037574:morpholine
Synteza pochodnych perhydroazepiny, perhydrO-1,5-oksazocyny, morfoliny I piperazyny zawierajacych reszte 3-(izopropyloamino)-propan-2-olowa--zwiazków o spodziewanym działaniu na układ krazenia i ośrodkowy układ nerwowy.